Evidence map›Paper›PMID 32630102›Full record

ArticleCells2020

Oxidative Inactivation of the Proteasome Augments Alveolar Macrophage Secretion of Vesicular SOCS3.

Mikel D Haggadone, Peter Mancuso, Marc Peters-Golden

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mikel D HaggadoneGraduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0002-7001-9132
Peter MancusoGraduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Marc Peters-GoldenGraduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.ORCID 0000-0002-9768-0262
University of Michigan · US

Funding

Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and FibrosisR35HL144979 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERS-GOLDEN, MARC L · 2019 to 2025
$6.5M
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell CrosstalkR01HL125555 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERS-GOLDEN, MARC L · 2015 to 2018
$2.2M
NIH HHS R01 HL125555NIH HHS R35 HL144979
6 · The paper itself

Abstract

Extracellular vesicles (EVs) contain a diverse array of molecular cargoes that alter cellular phenotype and function following internalization by recipient cells. In the lung, alveolar macrophages (AMs) secrete EVs containing suppressor of cytokine signaling 3 (SOCS3), a cytosolic protein that promotes homeostasis via vesicular transfer to neighboring alveolar epithelial cells. Although changes in the secretion of EV molecules-including but not limited to SOCS3-have been described in response to microenvironmental stimuli, the cellular and molecular machinery that control alterations in vesicular cargo packaging remain poorly understood. Furthermore, the use of quantitative methods to assess the sorting of cytosolic cargo molecules into EVs is lacking. Here, we utilized cigarette smoke extract (CSE) exposure of AMs as an in vitro model of oxidative stress to address these gaps in knowledge. We demonstrate that the accumulation of reactive oxygen species (ROS) in AMs was sufficient to augment vesicular SOCS3 release in this model. Using nanoparticle tracking analysis (NTA) in tandem with a new carboxyfluorescein succinimidyl ester (CFSE)-based intracellular protein packaging assay, we show that the stimulatory effects of CSE were at least in part attributable to elevated amounts of SOCS3 packaged per EV secreted by AMs. Furthermore, the use of a 20S proteasome activity assay alongside treatment of AMs with conventional proteasome inhibitors strongly suggest that ROS stimulated SOCS3 release via inactivation of the proteasome. These data demonstrate that tuning of AM proteasome function by microenvironmental oxidants is a critical determinant of the packaging and secretion of cytosolic SOCS3 protein within EVs.

Indexed as

AnimalsCells, CulturedExtracellular VesiclesFemaleMacrophages, AlveolarOxidantsOxidative StressProteasome Endopeptidase ComplexRatsRats, WistarReactive Oxygen SpeciesSecretory PathwaySuppressor of Cytokine Signaling 3 ProteinTobacco Smoke PollutionOxidantsProteasome Endopeptidase ComplexReactive Oxygen SpeciesSocs3 protein, ratSuppressor of Cytokine Signaling 3 ProteinTobacco Smoke Pollutionalveolar macrophage (AM)extracellular vesicles (EVs)proteasomereactive oxygen species (ROS)suppressor of cytokine signaling 3 (SOCS3)

Identifiers

PMID32630102
PMCPMC7408579
OpenAlexW3038459728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.